Alzinova AB: Alzinova finalises selection of seven US clinical sites as ADVANCE Phase 2a study moves toward first participant enrolment

Alzinova AB ("Alzinova" or the "Company") announces that it has finalised the selection of seven clinical trial sites in the United States for ADVANCE, its global Phase 2a study evaluating the vacc...